2020-21 SCID blood spot (pilot)

Scheme description
Molecular testing of newborn screening cards for TREC levels associated with Severe Combined Immunodeficiency (SCID).
Disorders/Gene target(s)
T-cell receptor excision circles (TRECs)
Clinical cases
Three
Testing/analysis
Index case only.
Test for number of TRECs.
Sample type
Newborn screening card
Techniques
Any methodology.
Assessment
Submit a proforma to include:
• TREC levels
Performance criteria are NOT applied.
Eligibility
All laboratories worldwide.
Languages
English
ISO1743 Accredited EQA
No
EQA timeline
Sample dispatchOctober 2020 TBC
Testing period6 weeks
Assessment resultsNovember 2020
Final Summary reportDecember 2020
Other information
Fee
£260.00
GenQA code
2020SCIDBS1
« Return to EQA scheme list
Go to top